REPORT FROM THE 25^TH CONGRESS OF THE EUROPEAN COMMITTEE  FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS (ECTRIMS) – AMSTERDAM, THE NETHERLANDS, OCTOBER 19-22, 2011 – The Omega-3 fatty acid Treatment in MS (OFAMS) study reports that omega-3 dietary supplementation has no significant effect on disease activity (Torkildsen et al. ECTRIMS 2011; abstract P919).